Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ragde

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Canadian Journal of Urology|June 1, 1997
Cancer immunotherapy for prostate cancerB. A. Tjoa, S. J. Erickson, V. A. Bowes, et al.
The Prostate|April 1, 1996
Measurement of prostate-specific membrane antigen in the serum with a new antibodyG P Murphy, W T Tino, E H Holmes, et al.
The Prostate|July 3, 1998
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptidesB A Tjoa, S J Simmons, V A Bowes, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
The Prostate|December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patientsG P Murphy, R T Maguire, B Rogers, et al.
The Prostate|February 11, 1999
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic diseaseG P Murphy, B A Tjoa, S J Simmons, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Canadian Journal of Urology|June 1, 1997
Cancer immunotherapy for prostate cancerB. A. Tjoa, S. J. Erickson, V. A. Bowes, et al.
The Prostate|April 1, 1996
Measurement of prostate-specific membrane antigen in the serum with a new antibodyG P Murphy, W T Tino, E H Holmes, et al.
The Prostate|July 3, 1998
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptidesB A Tjoa, S J Simmons, V A Bowes, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
The Prostate|December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patientsG P Murphy, R T Maguire, B Rogers, et al.
The Prostate|February 11, 1999
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic diseaseG P Murphy, B A Tjoa, S J Simmons, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Pageof 5